Oxytocin for Pain, Treatment Resistant Depression and Bipolar Disorder

.

.

.

Recent publications on Oxytocin are listed below. It is a very effective hormone made by the brain. It is NOT the opioid oxycodone and NOT oxycontin.

.

Use search function top left above photo to see previous postings on oxytocin since 2013. It can be extremely important in the treatment of intractable pain, treatment resistant depression, bipolar disorder or anxiety.

.

Once you titrate to the proper dose for each person —from 10 to 100 u’s, relief is quite astonishing, with rapid onset in a few minutes when given under the tongue – only after reaching that person’s dose, simple, without side effects. May use as needed 3 or 4 times per day. There is no withdrawal.

.

Avoid use if polycystic ovary syndrome (PCOS). 

.

Oxytocin must be made by a compounding pharmacy. Healthcare insurance refuses to reimburse for any compounded medications though they are far less expensive even than gabapentin that fails to help so many with pain, and oxytocin is far more effective. 

.

Every time you hug someone, you are giving each other oxytocin. When your dog and you stare at each other, oxytocin is being stimulated. Having discussed that with one of my patients, he came back one month later to say he and his wife had fallen in love again after almost 50 years of marriage because they’ve been hugging every day: hugs stimulate oxytocin. 

.

Behavioral effects of oxytocin are highly context- and person-dependent. You are not going to fall in love with someone you do not like. 

.

.

Rash, JA, et al: Oxytocin & Pain, A Systematic Review & Synthesis of Findings. Clin J Pain 30(5):453-462, May 2014.

.

Xin Q et al: The Analgesic Effects of Oxytocin in the Peripheral and Central Nervous System. Neurochemistry Intl 103:57-64, 2017.

.

Paloyelis Y et al: The Analgesic Effect of Oxytocin in Humans: A double-blind, placebo-controlled, cross-over study using laser-evoked potentials. 

.

MacDonald K, Feifel D. Oxytocin’s role in anxiety: a critical appraisal. Brain Res 2014; 1580: 22–56.

.

Churchland PPS, Winkielman P. Modulating social behavior with oxytocin: how does it work? What does it mean? Horm Behav 2012; 61: 392–399.

..

Bethlehem, R A I  et al: Intranasal oxytocin enhances intrinsic corticostriatal functional connectivity in women, Translational Psychiatry, 2017, 7, 4, e1099 ********excellent********

.
.

 

.

.

.

.

.

.

.

.

.

.

.

.

The material on this site is for informational purposes only.

.

It is not legal for me to provide medical advice without an examination.

.

It is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.

~~

Comments are welcome.

This site is not for email, not for medical questions, and not for appointments.

~~~~~

For My Home Page, click here:  Welcome to my Weblog on Pain Management!

.

Please IGNORE THE ADS BELOW. They are not from me.

.

.

.

.

.

..

..

.

.

.

 

 

.

.. 

 

 

 

Oxytocin, Astrocytes, Modification of Amygdala Circuits and Pain – IASP Early Research Career Grant Report

.

.

As a physician who prescribes Oxytocin [OT] and sees profound relief of many forms of intractable pain and/or relief of treatment refractory Major Depressive Disorder or Anxiety and Panic Disorder, this research on mechanisms is deeply meaningful and long awaited. Oxytocin is a hormone made in the brain, but also in the heart and other organs in women and men. It is rare to find work on glia and oxytocin.

.

Today the International Association for Study of Pain announced the final report from their 2012 Early Research Career Grant:

.

“Dr. Alexander Charlet of the Centre National de la Recherche Scientifique (CNRS) in Strasbourg, France, has submitted his final report for his project “Involvement of astrocytes in the endogenous oxytocin modification of amygdala microcircuits….”

.

“Dr. Charlet’s project focuses on the functional consequences of endogenous OT release in amygdala microcircuits on nociception and pain. In addition, he aims to decipher the precise mechanism, cellular and molecular, by which OT exerts its action. Thus, the purposes of his project are to characterize in vivo and in vitro the effects of endogenous OT in the amygdala on pain-related symptoms….

.

.….”In addition, he was surprised to discover that perceptions of his project’s importance grew once it was awarded and triggered future collaborations: a Marie Curie European Action Career Integration Grant and the French Initiative d’Excellence Attractivity.”

.

“As a result, Dr. Charlet also received two major personal prizes: an award from Swiss Society for Biological Psychiatry in 2012 and award from the French Académie nationale de medicine with the prestigious Albert Sézary price in 2013. Finally, he has been recruited as a neurosciences permanent researcher by the CNRS and recently opened his independent lab.”

.

.

.

~~~~~

The material on this site is for informational purposes only.

It is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.

~~~~~

Please understand that it is not legal for me

to give medical advice without a consultation.

If you wish an appointment, please telephone my office.

.

For My Home Page, click here:  Welcome to my Weblog on Pain Management!

.

.

.

Bipolar Disorder Treatment Resistant – Responds to Oxytocin & Ketamine

.

.

The patient is a Spanish speaking octogenarian who has Treatment Resistant Bipolar I Disorder with rapid cycling. In manic phases, she becomes aggressive and takes chances. Three of her siblings committed suicide in their late teens and early 20’s. The only time she has not been depressed was for eight months while caring for her dying husband ten years ago, and again, briefly, when she woke from coma 1-1/2 years ago after her most recent of many suicide attempts. She has been profoundly suicidal and lives alone with 24/7 caretakers. Her family lives one block away and keep most of her medications at their home.

.

She has bilateral heel pain and longstanding pain of both knees after total knee replacement. She sleeps six hours per night, often waking three times to void, and does not nap. No daytime sleepiness. She was blinded in one eye, and has partial sight in the other due to macular degeneration dry type. She weighs 57 kg.

.

Medications: She has failed every known medication. Cymbalta helped knee pain but caused her to become more depressed. Recent lithium toxicity led to the dose being lowered though blood levels were low, and she began using a walker one week ago due to vertigo. Lamotrigine was dropped from 400 to 200 mg/day, and Namenda 5 mg was started for knee pain. Azilect was discontinued eight days ago.

.

On examination, she had a very flat affect. She was very attentive and responded appropriately to questions translated for her. Her daughter and son-in-law demonstrated very tender care.

.

Treatment

.

The patient was given a small dose of oxytocin, a hormone made in the brain. Within one hour, she mentioned wanting Italian food — a clear sign to family that her depression was beginning to respond. Ketamine nasal spray was then discussed and a total of 10 mg was tested with no change in blood pressure or heart rate. Walking the long corridor to the elevator, she commented that pain was much better. The family indicates that if her depression responds to this, it will be the first time in more than fifty years.

.

The next day, family reported that instead of sleeping her usual six hours, she slept well, from 10:30 pm to 9:00 am. Symptoms began at 9:15 am. At 11:10 am, she was anxious, depressed, with suicidal ideation and knee pain was 6 on a scale of 10.

.

At 11:55 am, oxytocin was given and at 12:07 pm, 20 mg ketamine was given intra-nasally. By 12:15 am, depression, anxiety, suicidality and pain were zero. There was no change in blood pressure or pulse. Relief lasted almost five hours.

.

 At 4:30 pm, the caretaker reported she was crying profoundly for 10 minutes. At 5:00 pm, anxiety was rated 8, depression 10, suicidal ideation 10, pain 0. Ketamine 20 mg was given at 5:50 pm, and by 6:05 she reported no anxiety, depression or suicidality and no pain.

.

She returns tomorrow for her second visit. As we go forward, we will see duration of effect. She begins low dose naltrexone today after I advised her to stop tramadol a few days ago. She had been taking tramadol, a partial opioid, for pain of both knees and heels.

.

In my experience prescribing ketamine for more than eleven years, it is one of the safest medications I have ever prescribed.

.

My focus is on neuroinflammation and glia in the setting of chronic pain. There is tremendous overlap in pain systems and depression with strong evidence for the role of inflammation in both conditions. Ketamine is reported to be profoundly anti-inflammatory and acts more on glial receptors than its well known effect on the NMDA receptor.

.

That led me to prescribe another anti-inflammatory glial modulator for depression, low dose naltrexone (LDN). LDN antagonizes the Toll-Like Receptor 4 , the glial receptor that is a major component of the innate immune system in the brain and spinal cord. LDN has helped many of my patients who had intractable pain and a case report will be added soon that details the rapid response to LDN for a person with severe suicidality.

.

A review of inflammation and glia in depression was published by Yale psychiatrists in 2008 and discusses this in much greater detail.

.

Patients with Treatment Resistant Bipolar Disorder have reported that ketamine and oxytocin each help depression, but the combination works far better than would be predicted. It is hoped that persons with depression will benefit as much from addition of LDN that has helped so many with intractable pain who need ketamine much less because it is so effective. Of course these are preliminary observations after only several months, but they have been deeply rewarding. Much more work needs to be done, but in my opinion, these are a few of the key medications that have brought the greatest benefit to persons who have either pain or depression.

.

Third Visit

.

At her third visit last week, I sent the patient back long distance under the care of her psychiatrist with instructions to continue ketamine nasal spray and oxytocin. She apologized that she had not told the truth about her response to the medications. She had reported 100% improvement because she wanted to make her family feel better. Overall, she downgraded the rating of her depression as moderately better, and felt she was not 100%, because she still did not want to be alive. I pointed out that does not mean she is depressed, simply that she does not wish to be alive, an entirely different matter. As she spoke, she was smiling throughout the meeting.

.

Her family reported that she had been swimming, had walked one block to their home over the weekend, and today they tell me she has been swimming again, and plans to swim tomorrow.

.

To be continued.

.

.

The material on this site is for informational purposes only, and is not a substitute for

medical advice, diagnosis or treatment provided by a qualified health care provider.

.

~

Please understand that it is not legal for me

to give medical advice without a consultation.

If you wish an appointment, please telephone my office.

~

~

For My Home Page, click here:  Welcome to my Weblog on Pain Management!

~

.

.

.